Martino Bolognesi Selected Research

Martino Bolognesi Research Topics

Disease

12	Amyloidosis 01/2020 - 09/2004
11	Melioidosis 01/2022 - 01/2013
9	Neoplasms (Cancer) 12/2017 - 11/2002
7	Tuberculosis (Tuberculoses) 08/2007 - 06/2002
6	Infections 01/2023 - 08/2006
5	Hypoxia (Hypoxemia) 09/2013 - 05/2002
3	Virus Diseases (Viral Diseases) 09/2023 - 01/2012
3	Immunoglobulin Light-chain Amyloidosis 01/2023 - 01/2019
2	Renal Insufficiency (Renal Failure) 11/2022 - 07/2010
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 05/2015
2	Familial encephalopathy with neuroserpin inclusion bodies 02/2015 - 01/2012
2	Leprosy (Hansen's Disease) 09/2002 - 06/2002
1	Pneumonia (Pneumonitis) 01/2023
1	Inflammation (Inflammations) 11/2022
1	Chagas Disease (American Trypanosomiasis) 01/2022
1	Schistosomiasis (Bilharziasis) 04/2021
1	Rupture 02/2021
1	Cardiotoxicity 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Sepsis (Septicemia) 07/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2017
1	Burkholderia Infections 10/2017
1	Dengue (Dengue Fever) 10/2016
1	Chronic Disease (Chronic Diseases) 03/2016
1	Stroke (Strokes) 02/2015
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 03/2014
1	Caliciviridae Infections 02/2014
1	Gastroenteritis 01/2014
1	Stable Angina 01/2013
1	Prolidase Deficiency 01/2013
1	Shock 01/2013
1	Ischemia 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Dementia (Dementias) 08/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2010
1	Epilepsy (Aura) 08/2010

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 04/2021 - 05/2003
12	VaccinesIBA 09/2023 - 06/2011
9	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2003
9	AntigensIBA 01/2022 - 01/2013
6	EpitopesIBA 04/2021 - 01/2013
4	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020 - 12/2017
4	Oxygen (Dioxygen)IBA 05/2008 - 06/2002
3	LigandsIBA 02/2021 - 05/2004
3	Amino Acids FDA Link 01/2020 - 05/2002
3	Amyloidogenic ProteinsIBA 01/2020 - 03/2012
3	Peptides (Polypeptides)IBA 11/2016 - 01/2013
3	NeuroglobinIBA 09/2013 - 10/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2021
2	Immune Sera (Antisera)IBA 04/2021 - 11/2016
2	Heme (Haem)IBA 02/2021 - 09/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2018 - 04/2015
2	AntibodiesIBA 10/2017 - 04/2015
2	Inhibitor of Apoptosis ProteinsIBA 04/2015 - 01/2009
2	SerpinsIBA 02/2015 - 01/2012
2	NeuroserpinIBA 02/2015 - 01/2012
2	Antiviral Agents (Antivirals)IBA 02/2014 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 11/2012 - 12/2010
2	Truncated HemoglobinsIBA 08/2006 - 05/2004
2	NitratesIBA 08/2006 - 10/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2006 - 10/2003
2	NitrogenIBA 09/2002 - 06/2002
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	AA amyloidosisIBA 11/2022
1	imidazoleIBA 02/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	trehalose-phosphataseIBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 10/2017
1	Peptidoglycan (Murein)IBA 10/2017
1	HeE1-2TyrIBA 10/2016
1	Type V Secretion SystemsIBA 11/2015
1	Carrier Proteins (Binding Protein)IBA 05/2015
1	Myosins (Myosin)IBA 05/2015
1	Desmoplakins (Desmoplakin)IBA 05/2015
1	NF023IBA 04/2015
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2015
1	Neurofibromin 2 (Merlin)IBA 03/2014
1	Recombinant ProteinsIBA 09/2013
1	Hemeproteins (Heme Protein)IBA 09/2013
1	NitritesIBA 09/2013
1	Reducing AgentsIBA 01/2013
1	proline dipeptidase (prolidase)IBA 01/2013
1	IvabradineIBA 01/2013
1	decaneIBA 11/2012
1	Ivermectin (Mectizan)FDA Link 08/2012
1	CaspasesIBA 09/2009
1	Caspase 9IBA 09/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008
1	CytochromesIBA 08/2007
1	EnzymesIBA 08/2007
1	nitric oxide dioxygenaseIBA 08/2006
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2004
1	XenonIBA 05/2004

Therapy/Procedure

3	Therapeutics 04/2015 - 08/2009
1	Radiotherapy 01/2012
1	Drug Therapy (Chemotherapy) 01/2012
1	Renal Dialysis (Hemodialysis) 05/2008